Resolution to create biopsy test as companion diagnostic for niraparib

The cell-free DNA assay is currently being used to screen patients with prostate cancer in Phase II and III clinical trials. Credit: Mads Ryø Jochumsen, Bjørn Agerbo Sahlholdt and Jørgen Bjerggaard Jensen.



  • X-ray of hip